| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.8 |